Loading clinical trials...
Loading clinical trials...
The objective of this study is to describe and compare the incidence of adverse pregnancy outcomes (spontaneous abortion/miscarriage, stillbirth) and prevalence of adverse infant outcomes (major conge...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Regeneron Pharmaceuticals
Collaborators
NCT07298395 · Atopic Dermatitis (AD)
NCT07217015 · Atopic Dermatitis
NCT06116526 · Atopic Dermatitis
NCT06461897 · Atopic Dermatitis
NCT07262983 · Hyper IgE Syndrome From STAT3 Mutation, Job s Syndrome, and more
Regeneron Research Site
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions